Dravya Discovery is a specialist ophthalmology CRO built to support the translational development of innovative eye therapies. We combine deep ocular biology expertise with bespoke study design to generate high-quality, decision-enabling data that helps clients progress programmes with confidence.
What sets us apart is our partnership-driven approach. We work as an extension of your scientific team, tailoring each study to your specific therapeutic questions rather than applying one-size-fits-all solutions. Our focus on human-relevant, translational models enables more predictive insights, helping to de-risk development early and optimise downstream investment.
With clear communication, scientific rigour, and flexibility at the core of how we operate, Dravya Discovery delivers reliable results, transparent timelines, and actionable insight—supporting smarter decisions and faster progress in ophthalmic drug development.